| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Korean Journal of Otorhinolaryngology-Head and Neck Surgery > Volume 16(2); 1973 > Article
Korean Journal of Otorhinolaryngology-Head and Neck Surgery 1973;16(2): 35-40.
Nasopharyngeal Angiofibroma in Korea and its Treatment
Chin Kyu Cho, MD
Department of Otolaryngology, Medical School, Busan National University, Korea
우리나라에 있어서의 鼻咽腔 血管纖維腫과 그 治療法의 檢討
趙軫奎
釜山大學校 醫科大學 耳鼻咽喉科學敎室
ABSTRACT

Nasopharyngeal angiofibroma is histologically benign and characterized by potentially expansive growth. In the course of growth it encroaches upon the adjacent structures. It is so uncommon, that most authors have seen a small number of cases with the tumor. Therefore they have had different opinions as to the management and have performed surgically in ununiform manners. The author reviewed thoroughly the literatures of nasopharyngeal angiofibroma that appeared in our country during the period of 1958 to 1972, and then discussed sex and age distributions, during between the onset of first symptom and diagnosis, and treatment, using the material obtained from the literatures in addition to my own unreported cases. The results were as follows : 1) Of 46 cases of nasopharyngeal angiofibroma, 43 cases were males and only 3 cases were females. The onset was between 11 to 25 years of age in 43 cases, which was an average of 17.5 years. 2) At the time of treatment symptoms had been present for an average of one year and 8 months, the range being one month to 6 years. 3) Surgical treatment was the most frequently applied treatment and the transpalatine approach was preferred to others in Korea. During the operation blood loss was about, 1600ml on the average, and ranged from 600ml to 4,500ml. Blood loss seemed to be able to be reduced under hypothermic anesthesia. 4) Radiation therapy was used in a small number of cases with the tumor. It should have been given only to large or broad based tumor with the minimum required dosage, in order to reduce the size of the tumor and avoid frequent complications. 5) Hormone therapy was supposed to be a trial which seemed to have less complications than that of radiation therapy.

Editorial Office
Korean Society of Otorhinolaryngology-Head and Neck Surgery
103-307 67 Seobinggo-ro, Yongsan-gu, Seoul 04385, Korea
TEL: +82-2-3487-6602    FAX: +82-2-3487-6603   E-mail: kjorl@korl.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Society of Otorhinolaryngology-Head and Neck Surgery.                 Developed in M2PI
Close layer
prev next